Multidrug resistance in Acinetobacter baumannii is a growing public health concern all over the world. In the current study, the isolation and antimicrobial resistance pattern and detection of blaOXA-51 and lpxC genes by multiplex PCR method was performed. All the isolates demonstrated high levels of resistance rates to amikacin, ciprofloxacin, meropenem, imipenem, ceftriaxone, gentamicin, and colistin. Screening of two resistance genes by multiplex PCR showed that all the isolates contained blaOXA-51 and lpxC genes. As we previously reported, nosocomial infections caused by A. baumannii isolates are a major cause of morbidity and mortality in our hospital.
1.Background
Acinetobacter baumannii is a non-motile gram-negative and aerobic bacterium commonly isolated from the hospital environment and also hospitalized patients. A. baumannii is a nosocomial organism and preferentially colonizes aquatic environments. This organism is often cultured from sputum or respiratory secretions, wounds, skin and urine specimens of hospitalized patients.
A. baumannii is commonly associated with serious nosocomial infections worldwide; In this regard, Iran is no exception (1) (2) . In health care settings, A. baumannii is known for its ability to colonize or infect severely ill patients, particularly elderly. Moreover, it is extremely resistant to various antibiotics (3), particularly the carbapenemhydrolysing Class D b-lactamase, that is intrinsic in this bacterium. Similarly, colistin resistance in A. baumannii isolates has been reported from several countries (4) .
In Iran, dissemination of A. baumannii clones harboring carbapenem as well as colistin was reported (5-6).
2.Context
In this study, we documented eight cases of A. baumannii in a teaching hospital, Karaj.
Species identification had been performed previously using biochemical tests (7) . The antibiotic susceptibility of the strains was determined by the standard disk diffusion method on Mueller-Hinton agar according to CLSI guideline (8) . The following antibiotics were tested: imipenem, amikacin, gentamicin, ciprofloxacin, meropenem, ceftriaxoneand, and colistin.
All the Acinetobacter isolates were subjected to multiplex PCR assay in search for blaOXA-51 and lpxC genes using specific primers (9) .
Antibiotic susceptibility testing showed that all the isolates under study were resistant to ciprofloxacin, gentamicin, amikacin, meropenem, imipenem, ceftriaxone, and colistin.
Screening for carbapenemase-encoding genes by multiplex PCR showed that all the isolates contained the naturally occurring blaOXA-51 gene. Similarly, molecular analysis of the colistin-resistant isolates showed that all the isolates harbored lpxC resistance genes (Figure 1 ). 
3.Conclusion
Emergence of multidrug resistance among A. baumannii strains is a clinical problem affecting people health worldwide, making it as an important nosocomial pathogen which is able to acquire resistance to almost all routin antibiotics, including carbapenems (10) . In such cases, colistin is a key antimicrobial agent for treatment, however, increased prescription of this antibiotic has led to the emergence of colistin resistant A. baumannii isolates (11) .
Our study involved eight unique patients identified with infection due to multidrug resistant A. baumannii, which can be supported by the genetic relatedness of colistin-and carbapenem-resistant genes among these isolates. Therefore, in conclusion, it is recommended that the use of antibiotics to be well managed, and the establishment of a resistance monitoring system to be warranted.
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